eISSN: 1897-4317
ISSN: 1895-5770
Gastroenterology Review/Przegląd Gastroenterologiczny
Current issue Archive Manuscripts accepted About the journal Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank
4/2018
vol. 13
 
Share:
Share:
more
 
 
abstract:
Original paper

The relationship between 174 G/C and -572 G/C of IL-6 gene polymorphisms and susceptibility of celiac disease in the Iranian population

Zeinab Barartabar, Abdolrahim Nikzamir, Majid Sirati-Sabet, Elham Aghamohammadi, Vahid Chaleshi, Mohammad Rostami Nejad, Hamid Asadzadeh-Aghdaei, Mohammad Reza Zali

Gastroenterology Rev 2018; 13 (4): 293–298
Online publish date: 2018/12/11
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Introduction
Celiac disease (CD) is a chronic inflammatory intestinal disorder. Different immunological factors, including inflammatory cytokines, may play an important role in disease susceptibility.

Aim
To investigate the relationship between -174G/C and -572G/C gene polymorphisms and the serum level of interleukin 6 (IL-6) and susceptibility to CD in the Iranian population.

Material and Methods
In this case-control study blood samples were collected of 105 patients with CD and 106 healthy subjects randomly in 2016 and evaluated by polymerase chain reaction-restriction fragments length polymorphism (PCR-RFLP) method. A sequence was also used to confirm the results of both polymorphisms. The IL-6 concentration was measured using ELISA.

Results
The results showed a significant relationship between polymorphism -572G in CD patients when compared with control subjects by genotype (p = 0.001) and alleles (p = 0.022), respectively. There was no significant relationship between polymorphism 174G and frequency of genotype, but an association of this polymorphism with the frequency of alleles (p = 0.034), age (p = 0.001), and body mass index (p = 0.003) was seen. The serum level of interleukin-6 was significantly associated only with rs1800796 (p < 0.001).

Conclusions
The results confirm previous studies in different parts of the world and indicate that IL-6 (572G/C) polymorphism may play a role in susceptibility to CD in the Iranian population.

keywords:

celiac disease, polymerase chain reaction-restriction fragments length polymorphism, IL-6 gene polymorphism, autoimmune and inflammatory reaction

references:
Dieterich W, Ehnis T, Bauer M, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997; 3: 797-801.
Fasano A, Berti I, Gerarduzzi T, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the united states: a large multicenter study. Arch Inter Med 2003; 163: 286-92.
Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harbor Perspect Biol 2014; 6: a016295.
Rincon M. Interleukin-6: from an inflammatory marker to a target for inflammatory diseases. Trends Immunol 2012; 33: 571-7.
Clot F, Babron MC. Genetics of celiac disease. Mol Genet Metabol 2000; 71: 76-80.
de la Concha EG, Fernández-Arquero M, Vigil P, et al. Celiac disease and TNF promoter polymorphisms. Hum Immunol 2000; 61: 513-7.
Akbulut UE, Cebi AH, Sag E, et al. Interleukin-6 and interleukin-17 gene polymorphism association with celiac disease in children. Turk J Gastroenterol 2017; 28: 471-5.
Singh PK, Chandra G, Bogra J, et al. Association of interleukin-6 genetic polymorphisms with risk of OSCC in indian population. Meta Gene 2015; 4: 142-51.
Garrote JA, Arranz E, Gomez-Gonzalez E, et al. IL6, IL10 and TGFB1 gene polymorphisms in coeliac disease: differences between DQ2 positive and negative patients. Allergol Immunopathol 2005; 33: 245-9.
Manavalan JS, Hernandez L, Shah JG, et al. Serum cytokine elevations in celiac disease: association with disease presentation. Hum Immunol 2010; 71: 50-7.
Mazzarella G. Effector and suppressor T cells in celiac disease. World J Gastroenterol 2015; 21: 7349-56.
Amr K, El-Awady R, Raslan H. Assessment of the −174G/C (rs1800795) and −572G/C (rs1800796) interleukin 6 gene polymorphisms in Egyptian patients with rheumatoid arthritis. Open Access Maced J Med Sci 2016; 4: 574-7.
Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology 2000; 119: 234-42.
Trynka G, Wijmenga C, van Heel DA. A genetic perspective on coeliac disease. Trends Mol Med 2010; 16: 537-50.
Kapoor A, Patwari A, Kumar P, et al. Serum soluble interleukin-2 receptor, interleukin-6 and tumor necrosis factor alpha as markers of celiac disease activity. Indian J Pediatr 2013; 80: 108-13.
Romaldini CC, Barbieri D, Okay TS, et al. Serum soluble interleukin-2 receptor, interleukin-6, and tumor necrosis factor-alpha levels in children with celiac disease: response to treatment. J Pediatr Gastroenterol Nutrition 2002; 35: 513-7.
Nemec P, Pavkova-Goldbergova M, Stouracova M, et al. Polymorphism in the tumor necrosis factor-alpha gene promoter is associated with severity of rheumatoid arthritis in the Czech population. Clin Rheumatol 2008; 27: 59-65.
Ishihara K, Hirano T. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev 2002; 13: 357-68.
Kishimoto T. Interleukin-6: discovery of a pleiotropic cytokine. Arthritis Res Ther 2006; 8 Suppl 2: S2.
Barisani D, Ceroni S, Meneveri R, et al. IL-10 polymorphisms are associated with early-onset celiac disease and severe mucosal damage in patients of Caucasian origin. Genet Med 2006; 8: 169-74.
Li X, Chai W, Ni M, et al. The effects of gene polymorphisms in interleukin-4 and interleukin-6 on the susceptibility of rheumatoid arthritis in a Chinese population. BioMed Res Int 2014; 2014: 265435.
Godarzi EM, Sarvestani EK, Aflaki E, et al. Interleukin-6 gene polymorphism in Iranian patients with systemic lupus erythematosus. Clin Rheumatol 2011; 30: 179-84.
Yan J, Liu J, Lin CY, et al. Interleukin-6 gene promoter-572 C allele may play a role in rate of disease progression in multiple sclerosis. Int J Mol Sci 2012; 13: 13667-79.
Ma Y, Tang RK, Yang X, et al. Lack of an association between interleukin-6 gene promoter polymorphisms (−174G/C,− 572G/C) and ischemic heart disease and/or ischemic stroke: a meta-analysis. Hum Immunol 2011; 72: 641-51.
Fishman D, Faulds G, Jeffery R, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Investig 1998; 102: 1369-76.
Jerrard-Dunne P, Sitzer M, Risley P, et al. Inflammatory gene load is associated with enhanced inflammation and early carotid atherosclerosis in smokers. Stroke 2004; 35: 2438-44.
Sghaier I, Mouelhi L, Rabia NA, et al. Genetic variants in IL-6 and IL-10 genes and susceptibility to hepatocellular carcinoma in HCV infected patients. Cytokine 2017; 89: 62-67.
Woolley N, Mustalahti K, Mäki M, et al. Cytokine gene polymorphisms and genetic association with coeliac disease in the finnish population. Scand J Immunol 2005; 61: 51-6.
de Albuquerque Maranhão R, Martins Esteves F, Crovella S, et al. Tumor necrosis factor-alpha and interleukin-6 gene polymorphism association with susceptibility to celiac disease in italian patients. Genet Mol Res 2015; 14: 16343-52.
Dema B, Martinez A, Fernandez-Arquero M, et al. The IL6-174G/C polymorphism is associated with celiac disease susceptibility in girls. Hum Immunol 2009; 70: 191-4.
Quick links
© 2019 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe